|

TTI-101 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1/2: 2

Top Sponsors

  • University of Colorado, Denver1
  • Tvardi Therapeutics, Incorporated1

Indications

  • Cancer2
  • Liver Disease1
  • Pancreatic Cancer1
  • Liver Cancer1
  • Hepatocellular Carcinoma1

Birmingham, Alabama1 trial

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

The Kirklin Clinic of University of Alabama Birmingham Hospital

Phase 1/2

Aurora, Colorado1 trial

Phase I/IB Trial of Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

University of Colorado

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.